Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Barrett

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry|March 6, 2012
Synthesis and P2Y₂ receptor agonist activities of uridine 5'-phosphonate analoguesSara Van Poecke, Matthew O Barrett, T Santhosh Kumar, et al.
Surgical Infections|April 23, 2026
Risk Factors for Developing Candidemia after Gastrointestinal Perforation and/or Ischemia and Its Outcomes: A Matched Case-Control StudyMyeongji Kim, Nischal Ranganath, Sofia Molina Garcia, et al.
Journal of Medicinal Chemistry|May 3, 2011
Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptorHiroshi Maruoka, M P Suresh Jayasekara, Matthew O Barrett, et al.
Medchemcomm|July 11, 2015
4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y<sub>6</sub> receptorP Suresh Jayasekara, Matthew O Barrett, Christopher B Ball, et al.
Scientific Reports|March 4, 2024
Health Canada advisory impacts on the prevalence of oral codeine use in the Pediatric Canadian population: comparative study across provincesO Sheehy, S Eltonsy, S Hawken, et al.
Open Forum Infectious Diseases|June 1, 2026
Early Experience With Beta-Lactam Therapeutic Drug Monitoring in an Outpatient Parenteral Antimicrobial Therapy (OPAT) ProgramKemar O Barrett, Christina G Rivera, Omar Abu Saleh, et al.
Molecular Pharmacology|September 18, 2009
Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptorRhonda L Carter, Ingrid P Fricks, Matthew O Barrett, et al.
Journal of Medicinal Chemistry|May 8, 2010
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modificationsHiroshi Maruoka, Matthew O Barrett, Hyojin Ko, et al.
Bioconjugate Chemistry|February 4, 2010
Polyamidoamine (PAMAM) dendrimer conjugates of "clickable" agonists of the A3 adenosine receptor and coactivation of the P2Y14 receptor by a tethered nucleotideDilip K Tosh, Lena S Yoo, Moshe Chinn, et al.
Physical Chemistry Chemical Physics : PCCP|September 10, 2013
Characterisation of platinum-based fuel cell catalyst materials using 195Pt wideline solid state NMRGregory J Rees, Simon T Orr, Laurence O Barrett, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|March 6, 2012
Synthesis and P2Y₂ receptor agonist activities of uridine 5'-phosphonate analoguesSara Van Poecke, Matthew O Barrett, T Santhosh Kumar, et al.
Surgical Infections|April 23, 2026
Risk Factors for Developing Candidemia after Gastrointestinal Perforation and/or Ischemia and Its Outcomes: A Matched Case-Control StudyMyeongji Kim, Nischal Ranganath, Sofia Molina Garcia, et al.
Journal of Medicinal Chemistry|May 3, 2011
Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptorHiroshi Maruoka, M P Suresh Jayasekara, Matthew O Barrett, et al.
Medchemcomm|July 11, 2015
4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y<sub>6</sub> receptorP Suresh Jayasekara, Matthew O Barrett, Christopher B Ball, et al.
Scientific Reports|March 4, 2024
Health Canada advisory impacts on the prevalence of oral codeine use in the Pediatric Canadian population: comparative study across provincesO Sheehy, S Eltonsy, S Hawken, et al.
Open Forum Infectious Diseases|June 1, 2026
Early Experience With Beta-Lactam Therapeutic Drug Monitoring in an Outpatient Parenteral Antimicrobial Therapy (OPAT) ProgramKemar O Barrett, Christina G Rivera, Omar Abu Saleh, et al.
Molecular Pharmacology|September 18, 2009
Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptorRhonda L Carter, Ingrid P Fricks, Matthew O Barrett, et al.
Journal of Medicinal Chemistry|May 8, 2010
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modificationsHiroshi Maruoka, Matthew O Barrett, Hyojin Ko, et al.
Bioconjugate Chemistry|February 4, 2010
Polyamidoamine (PAMAM) dendrimer conjugates of "clickable" agonists of the A3 adenosine receptor and coactivation of the P2Y14 receptor by a tethered nucleotideDilip K Tosh, Lena S Yoo, Moshe Chinn, et al.
Physical Chemistry Chemical Physics : PCCP|September 10, 2013
Characterisation of platinum-based fuel cell catalyst materials using 195Pt wideline solid state NMRGregory J Rees, Simon T Orr, Laurence O Barrett, et al.
Pageof 7